Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local infiltration analgesia with ropivacaine, ketorolac, and adrenaline after total knee arthroplasty
2006-002673-52Phase 3Active
- Sponsor
- Universitetssjukhuset Örebro
- Start
- Aug 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine, ketorolac and epinephrine in postoperative pain and knee osteoarthritis (OA) (2 arms), sponsored by Universitetssjukhuset Örebro. Primary endpoint: Morphine consumption from end of surgery to 48 hours postoperatively. Started Aug 2006; status: active.
02
Drugs
ropivacaineketorolacepinephrine
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-002673-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002673-52.